EUDA Health Holdings Limited (EUDA)
NASDAQ: EUDA · Real-Time Price · USD
13.21
-0.99 (-6.97%)
At close: Aug 21, 2026, 4:00 PM EDT
13.20
-0.01 (-0.08%)
After-hours: Aug 21, 2026, 4:10 PM EDT
EUDA Health Holdings Employees
EUDA Health Holdings had 123 employees as of December 31, 2025. The number of employees increased by 6 or 5.13% compared to the previous year.
Employees
123
Change (1Y)
6
Growth (1Y)
5.13%
Revenue / Employee
$55,449
Profits / Employee
-$22,543
Market Cap
39.56M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 123 | 6 | 5.13% |
| Dec 31, 2024 | 117 | 11 | 10.38% |
| Dec 31, 2023 | 106 | -44 | -29.33% |
| Dec 31, 2022 | 150 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Altisource Portfolio Solutions | 1,236 |
| Fathom Holdings | 281 |
| Fangdd Network Group | 144 |
| Offerpad Solutions | 140 |
| J.W. Mays | 24 |
| Rafael Holdings | 23 |
| Seritage Growth Properties | 5 |
EUDA News
- 23 days ago - EUDA Health Announces Collaboration to Advance an Integrated iPSC Cell Therapy Program for Oncology and Wellness • Targets global distribution for innovative Oncology products - GlobeNewsWire
- 25 days ago - EUDA Health Signs Important Tri-Party Memorandum of Understanding with GO POSB Organoids and Shenzhen Inno to Significantly Advance Next-Generation iPSC and NK-TCR Cell Therapies - GlobeNewsWire
- 2 months ago - EUDA Health Expands Helixé Product Line with Launch of Regenixé iPSC-Derived Skin Stem Cell Secretome Mask - GlobeNewsWire
- 2 months ago - EUDA Health Regains Compliance with Nasdaq Continued Listing Requirements After Receipt of Nasdaq Notification Regarding Minimum Market Value Deficiency - GlobeNewsWire
- 4 months ago - EUDA Highlights Shenzhen Inno's Approval Under Shenzhen Key Industry R&D Program for TCR-T Cell Therapy Development - GlobeNewsWire
- 5 months ago - EUDA Announces Reverse Stock Split of its Ordinary Shares - GlobeNewsWire
- 6 months ago - EUDA Health Holdings Limited Announces Repurchase and Cancellation of Streeterville Warrant - GlobeNewsWire
- 7 months ago - EUDA Enters into Convertible Loan Agreement with Shenzhen Inno, Further Expanding Stem Cell Therapy Platform - GlobeNewsWire